natgillin/translations-raw huggingface dataset:
It can be as little as two times the MIC for Brachyspira hyodysenteriae and Actinobacillus pleuropneumoniae but as high as 50100 times the bacteriostatic level for Staphylococcus aureus.
Ta koncentracija je lahko samo dvakratna vrednost MIK, in sicer pri bakterijah Brachyspira hyodysenteriae in Actinobacillus pleuropneumoniae, pri Staphylococcus aureus pa je od 50- do 100-krat večja od bakteriostatske.
Concerning the indication ‘treatment and metaphylaxis of Airsacculitis and Infectious Synovitis caused by M. synoviae' two artificial infection studies and two old and one new field studies were presented to support the claim.
Pri indikaciji „zdravljenje in metafilaksa vnetja zračnih vrečk in infekcijskega sinovitisa, ki ju povzroča M. synoviae“ sta bili v podporo trditve predstavljeni dve študiji z umetno okužbo ter dve stari in ena nova terenska študija.
If signs of an interaction do occur, stop both the administration of tiamulin-medicated drinking water and also the administration of ionophore-contaminated feed immediately.
Če se pojavijo znaki medsebojnega delovanja, je treba takoj prenehati dajati vodo za pitje, ki vsebuje tiamulin, kot tudi krmo, kontaminirano z ionoforji.
Severe growth depression or death may result.
Lahko pride do hudega zaostajanja v rasti ali pogina.
Whereas
če obstajajo
If an interaction does occur, stop tiamulin medication immediately and replace with fresh drinking water.
Če pride do medsebojnega delovanja, takoj prenehajte z zdravljenjem s tiamulinom in vodo z dodatkom tiamulina zamenjajte s svežo vodo za pitje.
Considering all data available, the epidemiological cut-off value appeared to be at 0.5 µg/ml while less susceptible strains grouped at ≥2.0 µg/ml.
Glede na vse razpoložljive podatke naj bi bila epidemiološka mejna vrednost 0,5 µg/ml, vrednost manj občutljivih sevov pa je bila okrog ≥ 2,0 µg/ml.
It appears to be concentration-dependent with 500 mg tiamulin hydrogen fumarate (equivalent to 1.11 g of product) in 4 litres of water reducing intake by approximately 10% and 500 mg tiamulin hydrogen fumarate (equivalent to 1.11 g of product) in 2 litres of water by 15% in chickens.
Kaže, da je to odvisno od koncentracije, in sicer pri piščancih 500 mg tiamulinijevega hidrogenfumarata (kar ustreza 1,11 g zdravila) v 4 litrih vode zmanjša vnos za približno 10 %, 500 mg tiamulinijevega hidrogenfumarata (kar ustreza 1,11 g zdravila) v 2 litrih vode pa za 15 %.
The epidemiological cut-off value or wild-type MIC was approximately 0.5 µg/ml while resistance MICs appeared to begin at >2.0 µg/ml.
Epidemiološka mejna vrednost oziroma MIK divjega tipa je bila približno 0,5 µg/ml, MIK odpornosti pa naj bi se začela pri > 2,0 µg/ml.
See section 4.8 for information regarding interaction between tiamulin and ionophores.
Za informacije o medsebojnem delovanju tiamulina in ionoforjev glejte poglavje 4.8.
Lower doses of 8.8 mg tiamulin hydrogen fumarate/kg body weight were considered to give an inhibitory/bacteriostatic effect at the MIC90 level.
Manjši odmerki, 8,8 mg tiamulinijevega hidrogenfumarata/kg telesne mase, so imeli inhibitorni/bakteriostatični učinek na ravni MIK90.
If you notice any side effects, even those not already listed in this label, or you think that the medicine has not worked, please inform your veterinary surgeon.
Če opazite kakršne koli stranske učinke, tudi tiste, ki niso navedeni na tej stični ovojnini, ali mislite,
Serum protein-binding was approximately 50%.
Stopnja vezave na serumske beljakovine je bila približno 50 %.
eMIC50 was 4.0 µg/ml, eMIC90 8.0 µg/ml with an eMIC range of 1.0-32 µg/ml.
eMIK50 je bila 4,0 µg/ml, eMIK90 8,0 µg/ml z razponom eMIC med 1,0 in 32 µg/ml.
Tiamulin was administered for three days by gavage at 20-30 mg tiamulin hydrogen fumarate/kg body weight or in the drinking water.
Tiamulin so dajali v obdobju treh dni z gavažo v odmerku 20-30 mg tiamulinijevega hidrogenfumarata/kg telesne mase ali v pitni vodi.
The indication for treatment of Swine Dysentery caused by B. hyodysenteriae was re-evaluated through a review of literature and proprietary in vitro susceptibility data, and old clinical studies.
Indikacija za zdravljenje prašičje dizenterije, ki jo povzroča B. hyodysenteriae, je bila ponovno ovrednotena s pregledom literature in lastniških podatkov o občutljivosti in vitro ter starih kliničnih študij.
Due to technical constraints the susceptibility of Lawsonia intracellularis is difficult to test in vitro.
Zaradi tehničnih omejitev je težko testirati in vitro dovzetnost baketrije Lawsonia intracellularis.
The treatment of enzootic pneumonia caused by M. hyopneumoniae was investigated in two artificial infection studies and a series of eight field trials.
Zdravljenje enzootske pljučnice, ki jo povzroča M. hyopneumoniae, so preučevali v dveh študijah z umetno okužbo in v seriji osmih terenskih preskušanj.
In drinking water the 250 ppm (0.025%) tiamulin hydrogen fumarate concentration provided a rolling serum level over a 48 hour medication period of 0.78 µg/ml (range 1.40.45 µg/ml) and at 125 ppm (0.0125%), 0.38 µg/ml (range 0.65-0.2 µg/ml) in eight-week old chickens.
V vodi za pitje je tiamulinijev hidrogenfumarat v koncentraciji 250 ppm (0,025 %) pri 8 tednov starih piščancih v 48urnem obdobju zdravljenja zagotovil serumsko raven 0,78 µg/ml (razpon 1,4-0,45 µg/ml), v koncentraciji 125 ppm (0,0125 %) pa 0,38 µg/ml (razpon 0,65-0,2 µg/ml).
The MIC distribution for tiamulin against Brachyspira hyodysenteriae is bimodal, suggesting reduced susceptibility of some strains to tiamulin.
Porazdelitev MIK za tiamulin proti bakteriji Brachyspira hyodysenteriae je bimodalna, kar kaže na zmanjšano dovzetnost nekaterih sevov za tiamulin.
Denagard 45% has also been shown to be efficacious for the treatment of Enzootic Pneumonia caused by M. hyopneumoniae including infections complicated by Pasteurella multocida.
Zdravilo Denagard 45% je dokazano učinkovito tudi pri zdravljenju enzootske pljučnice, ki jo povzroča M. hyopneumoniae, vključno z okužbami, ki se zapletejo zaradi bakterije Pasteurella multocida.
The withdrawal periods have been revised following assessment of the available residue depletion data to ensure consumer safety.
Po oceni razpoložljivih podatkov o izločanju ostankov so bile karence zaradi zagotavljanja varnosti potrošnikov spremenjene.
Data reported from further studies (Felmingham, 20097; Kuzerova et al., 20118) confirm these findings with MIC50 and MIC90 of 8 µg/ml and 16 µg/ml resp. and MIC ranges of 0.25-16 µg/ml and 0.5-64 µg/ml.
Podatki, o katerih so poročali iz nadaljnjih študij (Felmingham, 20097; Kuzerova idr., 20118), potrjujejo te izsledke o MIK50 8 µg/ml in MIK90 16 µg/ml ter razponih MIK med 0,25 in 16 µg/ml in med 0,5 in 64 µg/ml.
In pigs appropriate GLP-compliant study data were provided to derive withdrawal periods for edible tissues for two different dosage regimens.
Pri prašičih so bili predloženi ustrezni podatki iz študije, skladne z dobro laboratorijsko prakso, iz katerih je bilo mogoče izpeljati karenco za užitna tkiva pri dveh različnih režimih odmerjanja.
At 60 ppm tiamulin hydrogen fumarate equivalent to 8-9 mg tiamulin hydrogen fumarate/kg body weight administered for three to five days the infected pigs showed significant improvements in clinical endpoints, pathological signs and elimination of B. hyodysenteriae.
Tiamulinijev hidrogenfumarat v odmerku 60 ppm, kar ustreza 8-9 mg tiamulinijevega hidrogenfumarata/kg telesne mase, ki so ga okuženim prašičem dajali tri do pet dni, je pokazal pomembno izboljšanje kliničnih opazovanih dogodkov, bolezenskih znakov in odstranitev B. hyodysenteriae.
The epidemiological cut-off value or wild-type MIC was approximately ≤0.25 µg/ml while resistance MICs appeared to begin at 0.5 µg/ml (first-step mutant) and 4.0 µg/ml (second-step mutant) (MAH proprietary data 2008).
Epidemiološka mejna vrednost oziroma MIK divjega tipa je bila približno ≤ 0,25 µg/ml, medtem ko naj bi se MIK odpornosti začela pri 0,5 µg/ml (prvostopenjski mutant) in 4,0 µg/ml (drugostopenjski mutant) (lastniški podatki imetnika dovoljenja za promet z zdravilom iz leta 2008).
In European isolates collected between 2009 and 2012 as part of the VetPath III project the following MICs of tiamulin were obtained: MIC50 of 8.0 µg/ml, MIC90 of 16 µg/ml, MIC range of 2.0-16 µg/ml.
Pri evropskih izolatih, zbranih med letoma 2009 in 2012 v okviru projekta VetPath III, so za tiamulin določili naslednje MIK: MIK50 8,0 µg/ml, MIK90 16 µg/ml, razpon MIK med 2,0 in 16 µg/ml.
The indication for treatment and metaphylaxis of Enzootic Pneumonia caused by M. hyopneumoniae, including infections complicated by P. multocida was supported by in vitro susceptibility data from the European MycoPath I project, proprietary clinical studies and literature.
Indikacijo za zdravljenje in metafilakso enzootske pljučnice, ki jo povzroča M. hyopneumoniae, vključno z okužbami, ki se zapletejo zaradi bakterije P. multocida, podpirajo podatki o občutljivosti in vitro evropskega projekta MycoPath I, lastniške klinične študije in literatura.
Tiamulin hydrogen fumarate is a bacteriostatic semi-synthetic antibiotic belonging to the pleuromutilin group of antibiotics and acts at the ribosomal level to inhibit bacterial protein synthesis.
Tiamulinijev hidrogenfumarat je bakteriostatični polsintetični antibiotik, ki spada v skupino plevromutilinskih antibiotikov ter deluje na ribosomski ravni in zavira sintezo bakterijskih beljakovin.
As long as combined use with these ionophores is avoided, especially in broilers, Denagard 45% has proven to be safe and effective in the treatment of airsacculitis, synovitis and sinusitis caused by M. gallisepticum, M. synoviae and/or M meleagridis in chickens and turkeys.
Če se kombinirani uporabi z navedenimi ionoforji izogibamo, zlasti pri pitovnih piščancih, je zdravilo Denagard 45% dokazano varno in učinkovito pri zdravljenju vnetja zračnih vrečk, sinovitisa in sinusitisa, ki jih povzročajo M. gallisepticum, M. synoviae oziromaM.
For the higher dosage (20 mg tiamulin hydrogen fumarate per kg body weight for up to five days) a GLP-compliant residue depletion study using a bioequivalent product containing 125 mg tiamulin hydrogen fumarate per ml (Tiamutin 12.5 % Solution) was provided.
Pri večjih odmerkih (20 mg tiamulinijevega hidrogenfumarata na kg telesne mase v obdobju do petih dni) je bila predložena študija o izločanju ostankov, skladna z dobro laboratorijsko prakso, v kateri so uporabljali biološko enakovredno zdravilo, ki je vsebovalo 125 mg tiamulinijevega hidrogenfumarata na ml (Tiamutin 12,5 % raztopina).
A. COMBINED LABEL-LEAFLET
A. ZDRUŽENO OZNAČEVANJE-NAVODILO ZA UPORABO
Tiamulin is a bacteriostatic semi-synthetic antibiotic belonging to the pleuromutilin group of antibiotics and acts at the ribosomal level to inhibit bacterial protein synthesis.
Tiamulin je polsintetični bakteriostatski antibiotik, ki spada v skupino plevromutilinskih antibiotikov in na ravni ribosomov zavira sintezo bakterijskih beljakovin.
Single oral doses of 100 mg tiamulin hydrogen fumarate/kg body weight in pigs caused hyperpnoea and abdominal discomfort.
Enkratni peroralni odmerki 100 mg tiamulinijevega hidrogenfumarata/kg telesne mase so pri prašičih povzročili hiperpnejo in trebušne težave.
• Increased MICs against B. hyodysenteriae isolates in different European Member States give rise for concern as there are only limited antimicrobials left for the treatment of swine dysentery.Porcine Proliferative Enteropathy (ileitis) caused by L. intracellularis: 8.8 mg tiamulin hydrogen fumarate (equivalent to 19.6 mg of product)/kg body weight administered daily in the drinking water of pigs for 5 consecutive days.
• Zvišanje MIK proti izolatom B. hyodysenteriae v različnih državah članicah je zaskrbljujoče, saj je za zdravljenje prašičje dizenterije na voljo le še omejeno število protimikrobnih zdravil.Prašičja proliferativna enteropatija (ileitis), ki jo povzroča L. intracellularis: Dnevni odmerek 8,8 mg tiamulinijevega hidrogenfumarata (kar ustreza 19,6 mg zdravila)/kg telesne mase v pitni vodi za prašiče v obdobju 5 dni zaporedoma.
In breeders on 0.025% tiamulin hydrogen fumarate the average serum level was 0.36 µg/ml (range 0.22-0.5 µg/ml).
Pri vzrejnih pticah, ki so prejele 0,025 % tiamulinijevega hidrogenfumarata, je bila povprečna serumska koncentracija 0,36 µg/ml (razpon 0,22-0,5 µg/ml).
Laying birds: Can be used in laying chickens and in breeding chickens and turkeys.
Lahko se uporablja pri piščancih v obdobju nesnosti ter pri vzrejnih piščancih in puranih.
When administered in the drinking water at 125, 250, or 500 ppm the estimated dose rates ranged from as low as 22 mg tiamulin hydrogen fumarate/kg body weight to a maximum of 102 mg tiamulin hydrogen fumarate/kg body weight.
Ko so ga dajali v pitni vodi v vsebnosti 125, 250 ali 500 ppm, so bili ocenjeni odmerki v razponu od najmanj 22 mg tiamulinijevega hidrogenfumarata/kg telesne mase do največ 102 mg tiamulinijevega hidrogenfumarata/kg telesne mase.
Clinical efficacy in the treatment of Porcine Colonic Spirochaetosis (colitis) caused by B. pilosicoli was demonstrated in three field trials.
Klinično učinkovitosti pri zdravljenju spirohetoze debelega črevesa (kolitisa) pri prašičih, ki jo povzroča B. pilosicoli, so dokazali v treh terenskih študijah.
Clinical efficacy in the treatment of swine dysentery caused by B. hyodysenteriae was demonstrated in two artificial infection studies and in a series of six field trials.
Klinično učinkovitost pri zdravljenju prašičje dizenterije, ki jo povzroča B. hyodysenteriae, so dokazali v dveh študijah z umetno okužbo in v seriji šestih terenskih preskušanj.
The CVMP agreed that although there is limited data for M. synoviae in comparison with M. gallisepticum, the available information from the studies provided is sufficient to support the conclusion that Denagard 45% at a dose of 25 mg tiamulin hydrogen fumarate (equivalent to 55.6 mg of product)/kg body weight for three to five consecutive days would be efficacious in the treatment and metaphylaxis of Airsacculitis and Infectious Synovitis caused by M. synoviae.
Odbor CVMP se je strinjal, da kljub omejenim podatkom za M. synoviae v primerjavi z M. gallisepticum razpoložljive informacije iz predloženih študij zadoščajo za potrditev zaključka, da je zdravilo Denagard 45% v odmerku 25 mg tiamulinijevega hidrogenfumarata (kar ustreza 55,6 mg zdravila)/kg telesne mase v obdobju treh do petih dni učinkovito pri zdravljenju in metafilaksi vnetja zračnih vrečk in infekcijskega sinovitisa, ki ju povzroča M. synoviae.
At 250 ppm tiamulin hydrogen fumarate administered for three days significant improvements in clinical endpoints, pathological signs and elimination of M. gallisepticum were shown.
Dokazali so, da tiamulinijev hidrogenfumarat v odmerku 250 ppm, ki so ga dajali tri dni, povzroči pomembno izboljšanje kliničnih opazovanih dogodkov, bolezenskih znakov in odstranitev M. gallisepticum.
For the lower dose (8.8 mg tiamulin hydrogen fumarate per kg body weight for up to five days) a study was conducted in 20 pigs treated via drinking water under field conditions.
Pri manjšem odmerku (8,8 mg tiamulinijevega hidrogenfumarata na kg telesne mase v obdobju do petih dni) so študijo izvedli pri 20 prašičih, ki so jih zdravili s pitno vodo v terenskih pogojih.
In the newer European strains and the older global isolates MIC ranges were similar for M. gallisepticum ranging from 0.001 - 0.037 µg/ml with MIC50s of 0,001 and 0.008 µg/ml and MIC90s of 0.025 and 0.031 µg/ml.
Pri novejših evropskih sevih in starejših globalnih izolatih M. gallisepticum so bili razponi MIK podobni, in sicer med 0,001 in 0,037 µg/ml, z MIK50s 0,001 in 0,008 µg/ml in MIK90s 0,025 in 0,031 µg/ml.
In the older European data there was a wider range of MICs for M. gallisepticum (<0.004 and >256 µg/ml) with a MIC50 of 0,008 µg/ml and a MIC90 of 1 µg/ml.
Pri starejših evropskih podatkih je bil pri M. gallisepticum večji razpon MIK (< 0,004 in > 256 µg/ml), z MIK50 0,008 µg/ml in MIC90 1 µg/ml.
Fresh solutions of tiamulin-medicated drinking water should be made up each day.
Vsak dan pripravite svežo raztopino vode za pitje z dodanim tiamulinom.
Colon contents concentrations of tiamulin have been estimated at 3.41 µg/ml following administration of tiamulin hydrogen fumarate at 8.8 mg/kg body weight.
Ocenjena koncentracija tiamulina v vsebini debelega črevesa je 3,41 µg/ml po dajanju tiamulinijevega hidrogenfumarata v odmerku 8,8 mg/kg telesne mase.
Use in drinking water or in feed
zrnca prašiči dajanje v vodo za pitje ali v krmo
Tiamulin, which has not been absorbed or metabolised, passes down the intestines to the colon.
Neabsorbirani ali nepresnovljeni tiamulin prehaja skozi prebavila v debelo črevo in se tam koncentrira.
• Meat and offal: 6 days
• Meso in organi: 6 dni
Animals received a mean dose of 29 mg tiamulin hydrogen fumarate /kg body weight for five days via drinking water; this
Živali so prejele povprečni odmerek 29 mg tiamulinijevega hidrogenfumarata/kg telesne mase v obdobju petih dni s pitno vodo.
In European isolates collected between 1990 and 2012 the minimum inhibitory concentration (MICs) ranged from ≤0.016 µg/ml to >16 µg/ml, with MIC50 of ≤0.063 µg/ml to 4 µg/ml and MIC90 of ≤0.016 µg/ml to >16 µg/ml.
Pri evropskih izolatih, zbranih med letoma 1990 in 2012, je bila minimalna inhibitorna koncentracija (MIK) v razponu med ≤ 0,016 µg/ml in > 16 µg/ml, MIK50 v razponu med ≤ 0,063 µg/ml in 4 µg/ml ter MIK90 v razponu med ≤ 0,016 µg/ml in > 16 µg/ml.
Withdrawal periods were calculated based on residue concentrations in liver and using the 99/95 tolerance interval to account for one residue concentration above the MRL at day 3 after treatment, resulting in a withdrawal period of 6 days calculated using the WT1.4 calculation program.
Karenco so izračunali na podlagi koncentracij ostankov v jetrih s tolerančnim intervalom 99/95, s čimer so upoštevali eno koncentracijo ostankov, ki je presegala najvišje mejne koncentracije ostankov 3. dan po zdravljenju.
The actual doses in mg/kg body weight were estimated at 8.8 mg mg tiamulin hydrogen fumarate/kg body weight.
Ocenili so, da je dejanski odmerek v mg/kg telesne mase 8,8 mg tiamulinijevega hidrogenfumarata/kg telesne mase.
Clinical efficacy in the treatment of Porcine Proliferative Enteropathy (ileitis) caused by L. intracellularis was demonstrated in three artificial infection studies and one field trial.
Klinično učinkovitost zdravljenja prašičje proliferativne enteropatije (ileitisa), ki jo povzroča L. intracellularis, so dokazali v treh študijah z umetno okužbo in enem terenskem preskušanju.
For meat and offal from turkey, a GLP-compliant residue depletion study was provided.
Za meso in notranje organe puranov je bila predložena študija izločanja ostankov, skladna z dobro laboratorijsko prakso.
The indication Pleuropneumonia caused by A. pleuropneumoniae was supported by in vitro susceptibility data and by artificial infection studies.
Indikacijo plevropnevmonije, ki jo povzroča A. pleuropneumoniae, podpirajo podatki o občutljivosti in vitro in študije z umetno okužbo.
At 55 mg tiamulin hydrogen fumarate/kg body weight given daily for 14 days, a transient salivation and slight gastric irritation occurred.
Pri odmerku 55 mg tiamulinijevega hidrogenfumarata/kg telesne mase, ki so ga dajali 14 dni, je prišlo do prehodnega slinjenja in rahlega draženja želodca.
Tiamulin hydrogen fumarate
tiamulinijev hidrogenfumarat
Name and address of the marketing authorisation holder and of the manufacturing authorisation holder responsible for batch release, if different
Ime in naslov imetnika dovoljenja za promet z zdravilom ter proizvajalec zdravila,
Target species pigs, indications and posology
Ciljna vrsta prašiči, indikacije in odmerjanje
antibacterial for systemic use / Pleuromutilins / tiamulin
Farmakoterapevtska skupina: zdravila za sistemsko zdravljenje bakterijskih infekcij/plevromutilini/tiamulin.
• Meat and offal: 2 days
• Meso in organi: 2 dni
Tiamulin hydrogen fumarate 450 mg
Vsak gram vsebuje: tiamulinijev hidrogenfumarat 450 mg
McOrist et al. (1995)3 examined three strains of L. intracellularis to find intracellular MIC (iMIC) and extracellular MIC (eMIC)
(1995)3 so preučevali tri seve L. intracellularis in ugotovili, da sta znotrajcelična MIK (iMIK) in zunajcelična MIK (eMIK) tiamulina 4 µg/ml.
During this referral, adequate data have been submitted to support the following indications: Pigs
Ocena koristi V tej napotitvi so bili predloženi ustrezni podatki v podporo naslednjim indikacijam:
• the CVMP reviewed the summary of product characteristics, labelling and package leaflet proposed by the marketing authorisation holders and considered all the overall submitted data; the CVMP has recommended the amendment of the marketing authorisations for Denagard 45% and its associated names as referred in Annex I for which the summary of product characteristics, labelling and package leaflet are set out in Annex III.
odbor CVMP je priporočil spremembo dovoljenj za promet z zdravilom za zdravilo Denagard 45% in povezana imena, navedena v Prilogi I, za katera so v Prilogi III navedeni povzetek glavnih značilnosti zdravila, označevanje in navodilo za uporabo.
Artificial challenge studies were carried out using tiamulin inclusion rates in drinking water ranging from 120 to 180 ppm equivalent to doses of 20 to 40 mg tiamulin hydrogen fumarate/kg body weight.
Opravljene so bile študije z umetno izpostavitvijo, v katerih je bila uporabljena vsebnost tiamulina v pitni vodi med 120 in 180 ppm, kar ustreza odmerkom od 20 do 40 mg tiamulinijevega hidrogenfumarata/kg telesne mase.
A withdrawal period of 4 days was calculated based on residue concentrations in liver tissues using the WT1.4 calculation program and setting values below limit of quantification (LOQ) at ½ LOQ according to the CVMP note for guidance “Approach towards harmonisation of withdrawal periods” (EMEA/CVMP/036/95)9.
Pri vsakem prašiču so odvzeli vzorce jeter in mišic ter v njih analizirali vsebnost 8-α-hidroksimutilina z validirano analitsko metodo LCMS-MS. Na podlagi koncentracij ostankov v jetrnem tkivu so izračunali karenco 4 dni, in sicer z računskim programom WT1.4 in nastavljenimi vrednostmi pod mejo določljivosti pri polovičnih vrednostih meje določljivosti v skladu z navodili odbora CVMP „Pristop k usklajevanju karenc“ (EMEA/CVMP/036/95)9.
The words “Keep out of the sight and reach of children” Keep out of the sight and reach of children.
Besedilo “Zdravilo shranjujte nedosegljivo otrokom” Zdravilo shranjujte nedosegljivo otrokom.
Aluminium foil sachets of 55.6 g and 111.2 g
Vrečke iz aluminijaste folije, ki vsebujejo 55,6 g in 111,2 g. Oblikovana vrečka iz folije, ki vsebuje 1112 g in 5000 g.
The presence of the disease in the herd must be established before the product is used.
Pred uporabo zdravila je treba ugotoviti prisotnost bolezni v čredi.
Dose-related reductions in mortality, average lung lesion area and A. pleuropneumoniae re-isolation but no complete clinical cure were observed at lower doses (20 mg).
Pri manjšem odmerku (20 mg) so opazili od odmerka odvisno zmanjšanje umrljivosti, povprečne površine pljučnih lezij in ponovne izolacije A. pleuropneumoniae, ne pa popolne klinične ozdravitve.
For edible tissues and based on residue concentrations in liver, a withdrawal period of 26.2 hours was calculated using the WT1.4 calculation program, rounded up to 2 days.).
Na podlagi koncentracij ostankov v jetrih so z računskim programom WT1.4 za užitna tkiva določili karenco 26,2 ure (zaokroženo na 2 dni).
PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGE - COMBINED LABEL AND PACKAGE LEAFLET
PODATKI KI MORAJO BITI NAVEDENE NA STIČNI OVOJNINI - ZDRUŽENA STIČNA
In the field trials tiamulin was administered at inclusion rates of 125 - 250 ppm and estimated doses from 13.3 - 32.5 mg tiamulin hydrogen fumarate/kg body weight for three days.
V terenskih preskušanjih je bila uporabljena vsebnost tiamulina 125-250 ppm in ocenjeni odmerki 13,3-32,5 mg tiamulinijevega hidrogenfumarata/kg telesne mase v obdobju treh dni.
The indication Porcine Colonic Spirochaetosis (colitis) caused by B. pilosicoli was supported by in vitro susceptibility data and field studies.
Indikacijo spirohetoze debelega črevesa (kolitisa) pri prašičih, ki jo povzroča B. pilosicoli, podpirajo podatki o občutljivosti in vitro in terenske študije.